Ledger.Open graph →
SEC Form D · filed August 9, 2023

Forte Biosciences, Inc

Offering
$25.0M
Sold
$25.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DALLAS, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Stephen Doberstein · Dallas, TXDirectorScott Brun · Dallas, TXDirectorHubert Chen · Dallas, TXExecDavid Gryska · Dallas, TXDirectorPaul Wagner · Sherman Oaks, CAExec · DirectorAntony Riley · Dalla, TXExecLawrence Eichenfield · Sherman Oaks, CADirectorSteven Kornfeld · Burlingame, CADirectorBarbara Fink · Dallas, TXDirectorDonald Williams · Radcliffe, IADirectorPaul Wagner · Portland, ORExec · DirectorLawrence Eichenfield · Sherman Oaks, CADirectorAntony Riley · Dalla, TXExecStephen Doberstein · Dallas, TXDirectorScott Brun · Dallas, TXDirectorHubert Chen · Dallas, TXExecSteven Kornfeld · Burlingame, CADirectorDavid Gryska · Dallas, TXDirectorBarbara Fink · Dallas, TXDirectorDonald Williams · Dallas, TXDirectorPaul Wagner · Sherman Oaks, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗